Health
Metformin use reduces risk of death for patients with Covid-19, diabetes – Hindustan Times
Use of the diabetes drug metformin, before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of Covid-19 is associated with a threefold decrease in mortality in Covid-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.
Diabetes is a significant comorbidity for Covid-19.
“This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure,” said Anath Shalev, M.D., director of UAB’s Comprehensive…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience
-
General23 hours agoBack-to-back rate cuts tipped when Reserve Bank meets